Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Q3 2025 value amounting to 0.15%.

  • Arcutis Biotherapeutics' Return on Invested Capital rose 3300.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 3300.0%. This contributed to the annual value of 0.46% for FY2024, which is 2300.0% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Return on Invested Capital of 0.15% as of Q3 2025, which was up 3300.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Return on Invested Capital registered a high of 0.15% during Q3 2025, and its lowest value of 0.95% during Q3 2023.
  • Moreover, its 3-year median value for Return on Invested Capital was 0.47% (2025), whereas its average is 0.53%.
  • In the last 5 years, Arcutis Biotherapeutics' Return on Invested Capital surged by 4900bps in 2024 and then soared by 800bps in 2025.
  • Arcutis Biotherapeutics' Return on Invested Capital (Quarter) stood at 0.91% in 2023, then surged by 55bps to 0.41% in 2024, then surged by 63bps to 0.15% in 2025.
  • Its Return on Invested Capital stands at 0.15% for Q3 2025, versus 0.35% for Q2 2025 and 0.47% for Q1 2025.